ASTX030

Overview

ASTX030 is an oral DNMT inhibitor that is a combination of cedazuridine and azacitadine. It's being studied for use in several different indications.

SparkCures ID 708
Generic Name ASTX030
Treatment Classifications
  • DNMT1 Inhibitor

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.